LionBird
LionBird is a Tel Aviv- and Evanston-based venture capital firm founded in 2012 that invests exclusively in pre-scale digital health startups, managing over $150 million in AUM across 35+ portfolio companies. It provides early-stage capital, GTM support, and access to a healthcare executive network through its LionBird Rings community.
- Company typePrivate
- Founded2012
- HeadquartersTel Aviv, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
What LionBird does
LionBird is a venture capital firm founded in 2012 and headquartered in Tel Aviv, Israel, with a North American office in Evanston, Illinois. The firm invests exclusively in pre-scale digital health startups, providing early-stage capital and hands-on operational support including go-to-market assistance, strategic advisory, warm introductions to downstream investors, and access to senior healthcare operators via its LionBird Rings community. Since inception, LionBird has invested in more than 35 founding teams and manages over $150 million in assets under management, with a claimed 80%+ follow-on financing rate versus a 20% industry benchmark.
The firm's portfolio is concentrated in digital health across multiple sub-verticals, including AI-enabled virtual examination (Tyto Care), healthcare compliance analytics (Protenus, acquired by Thoma Bravo), cancer recurrence monitoring (C2i Genomics, acquired by Veracyte), senior virtual primary care (Heyday Health), elder care navigation (Mellie), behavioral health AI (Jimini Health), federated healthcare AI infrastructure (Rhino Health), and ML-based clinical trial optimization (PhaseV). Notable co-investors across the portfolio include a16z, Khosla Ventures, General Catalyst, Accel, Oak hc/ft, Viola, and UpWest, with strategic content collaborations with TELUS Global Ventures.
LionBird's business model is venture capital returns: the firm generates revenue through management fees on committed capital and carried interest on exits, reserving follow-on funds to support portfolio companies across subsequent financing rounds. The firm operates a relationship-driven, sales-led go-to-market focused on warm introductions, founder referrals, and content-led marketing (LionBird Bites monthly newsletter, LionBird Wings quarterly newsletter, and a library of whitepapers covering IDNs, self-insured employers, hospital SaaS, SNFs, MAOs, and pharma R&D). The team comprises partners with backgrounds spanning Fortune 100 healthcare operations (Ed Michael, former EVP at Abbott Laboratories), prior VC and operating experience (Gal Noyman Veksler, ex-aMoon and NeuroLabs AI), and serial entrepreneur exits (Chaim Friedman, STARLIMS IPO and Abbott acquisition; Robert Lord, Protenus co-founder).
LionBird firmographics
Firmographics- Name
- LionBird
- Legal name
- LionBird (Ventures) Ltd
- Website
- https://lionbird.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LionBird is a Tel Aviv- and Evanston-based venture capital firm founded in 2012 that invests exclusively in pre-scale digital health startups, managing over $150 million in AUM across 35+ portfolio companies. It provides early-stage capital, GTM support, and access to a healthcare executive network through its LionBird Rings community.
- Ownership category
- akta.pro rank
LionBird industry classification
Industry- Product category
- Venture Capital / Digital Health Investment
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)
Keywords
Where LionBird is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
LionBird business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture Capital Returns: LionBird generates returns through equity investments in early-stage digital health companies. The firm takes equity stakes in portfolio companies and realizes returns through exits via acquisitions or public offerings. They reserve follow-on funds to invest in future capital requirements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
LionBird product offering
Product offeringCore offering
LionBird is a venture capital firm that invests exclusively in pre-seed to seed-stage digital health startups, providing pre-scale capital alongside hands-on operational support, including go-to-market strategy, strategic advisory, warm introductions to downstream institutional investors, and access to a community of healthcare executives (LionBird Rings). It has invested in more than 35 founding teams and manages over $150 million in assets under management.
Product overview
LionBird is a venture capital firm investing exclusively in pre-scale digital health companies. Since its inception, the firm has invested in more than 35+ founding teams and now has over $150 million in AUM. Rather than operating a software product business, LionBird provides pre-scale capital, strategic guidance, and operational support to healthcare technology startups. The firm offers investment services, founder resources (including whitepapers, cheat sheets on market segments like SNF, MAO, IDN, and self-insured employers), networking opportunities through LionBird Rings (a community of healthcare executives), and educational content via the LionBird Bites newsletter. LionBird does not develop or sell its own software products or platforms.
Differentiator
Problem solved
Functional benefit
Brands
- LionBird Bites: Monthly newsletter aggregating digital health news and insights, read by VC industry professionals
- LionBird Wings
Products and services
- Pre-Scale Venture Capital Investment
Quantifiable outcome
- 80%+ of LionBird's initial investments attract significant institutional-led follow-on financing (vs 20% industry average)
- +1 more outcomes
Companies that use LionBird
Customer profileNamed customers8 records
Segments1 record
Ideal customer profiles1 record
LionBird technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
LionBird partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- TELUS Global VenturescoreTELUS Global Ventures collaborated with LionBird on the Women's Health whitepaper/report, with Managing Partner Terry Doyle providing endorsement and Ravit Warsha Dor as co-author.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
LionBird competitors and assessment
Company assessmentDirect peers
- Oak HC/FT: Early- and growth-stage healthcare and fintech investor that has co-invested with LionBird in Black Ore; a natural peer in digital health specialization.
- Flare Capital Partners: Healthcare technology-focused early-stage VC supporting founders building innovative solutions for the healthcare ecosystem; directly comparable pre-seed/seed digital health investor.
- 7wireVentures: Consumer-focused digital health early-stage investor with operator support model, similar vertical specialization and stage to LionBird.
- Define Ventures: Early-stage digital health specialist VC investing across providers, payors, and healthcare IT, closely comparable to LionBird's pre-scale digital health thesis and stage focus.
- Town Hall Ventures: Healthcare-focused VC that co-invested with LionBird in the Jimini Health seed round; comparable healthcare-only specialist mandate.
- .406 Ventures: Early-stage investor in healthcare IT and cybersecurity; similar pre-seed/seed healthcare technology orientation.
- Define Health Ventures: Digital health-specific early-stage operator-led VC; an investor comparable to LionBird on focus, stage, and operator support model.
Broad incumbents
- General Catalyst: Large multi-stage VC with a dedicated health practice that has co-invested with LionBird in Ecton; similar stage overlap in digital health seed deals but operates a much larger fund platform.
- Optum Ventures: Corporate venture arm of UnitedHealth's Optum focused on digital health and care delivery; invests across stages as a strategic partner rather than as a pure financial VC.
- Andreessen Horowitz (a16z Bio/Health Fund): Generalist Tier-1 VC with a dedicated Bio/Health fund that has co-invested with LionBird in Black Ore; broader franchise but overlapping digital health deal flow at the seed stage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
LionBird social profiles
Digital presenceLionBird financial estimates
Financial estimateRevenue estimate
Valuation estimate
LionBird leadership team
Management profileNumber of profiles
Profiles10 records
LionBird funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LionBird M&A and investment
M&A and investmentM&A
Investments72 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LionBird
What does LionBird do?
LionBird is a venture capital firm that invests exclusively in pre-seed to seed-stage digital health startups, providing pre-scale capital alongside hands-on operational support, including go-to-market strategy, strategic advisory, warm introductions to downstream institutional investors, and access to a community of healthcare executives (LionBird Rings). It has invested in more than 35 founding teams and manages over $150 million in assets under management.
Is LionBird a public or private company?
LionBird is a private company. It is classified as management employee owned and is currently operating.
When was LionBird founded?
LionBird was founded in 2012. It employs 11 to 50 people.
Where is LionBird based?
LionBird is headquartered in Tel Aviv, Israel, in the Middle East region.
How does LionBird make money?
One revenue line is on record: venture Capital Returns.
Who are LionBird's main competitors?
Direct peers on record are Oak HC/FT, Flare Capital Partners, 7wireVentures, Define Ventures, Town Hall Ventures, .406 Ventures and Define Health Ventures. Broad incumbents are General Catalyst, Optum Ventures and Andreessen Horowitz (a16z Bio/Health Fund).
Does LionBird have an API?
No public API is recorded for LionBird.
What industry is LionBird in?
LionBird's product category is Venture Capital / Digital Health Investment. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed). Its NAICS code is 525 and its SIC code is 6282.